Diagnostic patch testing following tuberculosis‐associated cutaneous adverse drug reactions induces systemic reactions in<scp>HIV</scp>‐infected persons

Abstract

In HIV-infected persons with tuberculosis-associated CADR, although patch-testing reactions to FLTD are common and tend to be associated with systemic features, they are not life threatening or fatal. These data inform clinical practice in HIV-endemic settings.